This study is the first one designed to analyze the role of TREML2 rs3747742 in the pathogenesis of AD by examining the relation of rs3747742 with CSF proteins, neuroimaging biomarkers and cognitive function in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) database. The gene discussed is TREML2; the disease is early-onset autosomal dominant Alzheimer disease.